GlaxoSmithKline Consumer Healthcare
BSE: 500676 | NSE: GSKCONS | ISIN: INE264A01014 | Food Processing
 |
 |
Yearly Results of GlaxoSmithKline Consumer Healthcare |
------------------- in Rs. Cr. ------------------- |
| ||||||||||
|
||||||||||
| Dec '04 | Dec '05 | Dec '06 | Dec '07 | Dec '08 | ||||||
|
||||||||||
| Sales Turnover | 862.17 | 966.85 | 1,111.90 | 1,277.80 | 1,592.30 | |||||
| Other Income | 25.49 | 24.31 | 52.20 | 68.90 | 45.96 | |||||
| Total Income | 887.66 | 991.16 | 1,164.10 | 1,346.70 | 1,638.26 | |||||
| Total Expenses | 729.87 | 782.67 | 932.00 | 1,053.50 | 1,305.26 | |||||
| Operating Profit | 132.30 | 184.18 | 179.90 | 224.30 | 287.04 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 157.79 | 208.49 | 232.10 | 293.20 | 333.00 | |||||
| Interest | 5.25 | 4.22 | 3.50 | 4.60 | 6.97 | |||||
| PBDT | 152.54 | 204.27 | 228.60 | 288.60 | 326.03 | |||||
| Depreciation | 36.86 | 41.85 | 38.10 | 43.50 | 41.95 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 115.68 | 162.42 | 190.50 | 245.10 | 284.08 | |||||
| Tax | 42.52 | 55.27 | 63.60 | 82.50 | 95.75 | |||||
| Net Profit | 73.16 | 107.15 | 126.90 | 162.60 | 188.33 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 16.12 | 25.48 | 30.14 | 38.62 | 44.78 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 45.38 | 42.06 | 42.10 | 42.10 | 42.06 | |||||
| Reserves | 483.97 | 433.06 | 500.70 | 604.30 | -- | |||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore GlaxoSmith Con connections | ||||||||||
| ||||||||||
